Faeth Therapeutics Welcomes Dr. Stephen Hahn and Dr. Jayson Dallas to Board
Key Highlights Dr. Stephen Hahn, former FDA Commissioner, joins as a Board member, contributing expertise in oncology and…
Browsing Tag
Food and Drug Administration (FDA)
2 posts
Gilead Acquires CymaBay in $4.3 Billion Deal
Key Highlights Gilead Sciences announces acquisition of CymaBay Therapeutics for $4.3 billion, bolstering its liver disease treatment offerings. Seladelpar, CymaBay’s lead product…